Slideshow
Author(s):
Eighteen percent of all improperly used thrombolytic treatments in the emergency department occur in patients with migraine with aura.
FDA Approves First Autoinjector Form of DHE for Acute Migraine and Cluster Headache
Sleeping Around the Podcast × NeurologyLive: Erenumab, Migraine, and Sleep
FDA Action Update, April 2025: Approvals, Expansion, and Authorization
Sleeping Around the Podcast × NeurologyLive: Calcitonin Gene-Related Peptide in Sleep Research
Eric Baron, DO, on the Approval of CT-132: A Digital Shift in Migraine Care
NeurologyLive® Friday 5 — May 2, 2025